emtricitabine/tenofovir vs ganciclovir
Side-by-side comparison of emtricitabine/tenofovir and ganciclovir. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
minor Known Drug Interaction
Some examples include, but are not limited to, acyclovir, adefovir dipivoxil, cidofovir, ganciclovir, valacyclovir, valganciclovir, aminoglycosides (e.g., gentamicin), and high-dose or multiple NSAIDs [see Warnings and Precautions (5.3) ] .
Recommendation: Your doctor should monitor your kidney health and check for side effects while you are using these drugs.
Truvada, Descovy
Cytovene
Truvada is a medicine that contains two drugs, emtricitabine and tenofovir. It is used to treat HIV-1 infection and to prevent getting HIV-1.
Ganciclovir injection is an antiviral medicine. It helps treat and prevent cytomegalovirus (CMV) infections.
Truvada is used to treat HIV-1 infection in adults and children who weigh at least 37 pounds. It must be used with other HIV medicines. Truvada can also be used to help prevent getting HIV-1 in adults who are at high risk. When used for prevention, it is called PrEP (pre-exposure prophylaxis) and should be used with safer sex practices.
This medicine treats CMV retinitis, an eye infection, in people with weak immune systems, including those with AIDS. It also prevents CMV disease in adults who have had organ transplants and are at risk for CMV.
Truvada contains two medicines that block HIV-1 reverse transcriptase. This enzyme is needed for HIV to multiply. By blocking this enzyme, Truvada helps to lower the amount of HIV in your body and prevent HIV infection.
Ganciclovir stops CMV from multiplying. It does this by blocking a key enzyme the virus needs to make copies of itself. This helps your body fight off the CMV infection.
- • Diarrhea
- • Nausea
- • Tiredness
- • Headache
- • Dizziness
- • Fever
- • Diarrhea
- • Low white blood cell count
- • Nausea
- • Anemia (low red blood cell count)
- Drug Interaction 655
- Foetal Exposure During Pregnancy 621
- Anxiety 432
- Drug Resistance 431
- Virologic Failure 402
- CMV infection 1,170
- The virus is not responding to the medicine 653
- Fever 590
- Low count of a type of white blood cell 503
- Low count of all types of blood cells 503
Truvada can cause serious side effects, including lactic acidosis and severe liver problems. Tell your doctor right away if you have any symptoms of these problems. If you have hepatitis B and stop taking Truvada, your hepatitis B may get worse. Your doctor will need to monitor you closely for several months if you stop taking Truvada. If you are using Truvada to prevent HIV, you must be tested to be sure you do not have HIV. If you take Truvada when you have HIV, the HIV virus can become resistant to the medicine.
This drug can cause serious side effects. It can lower blood cell counts, possibly leading to severe infections or bleeding. It may also harm fertility in both men and women. Ganciclovir can cause birth defects and may increase your risk of cancer. Talk to your doctor about these risks.
Tell your doctor if you are pregnant or plan to become pregnant. Truvada should be used during pregnancy only if clearly needed. If you are infected with HIV, you should not breastfeed because you could pass HIV to your baby.
Ganciclovir can harm your unborn baby. Do not get pregnant while taking this medicine. Talk to your doctor about birth control. Breastfeeding is not recommended while using this medicine.
Also Compare, Nearby Drugs
Compare ganciclovir with
How to Read This emtricitabine/tenofovir vs ganciclovir Comparison
emtricitabine/tenofovir is classified in the NRTI Combination (HIV PrEP) drug class, while ganciclovir sits within the Antiviral (Nucleoside Analog) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, emtricitabine/tenofovir has 2,541 submissions while ganciclovir has 3,419. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known minor interaction flagged in FDA labeling, attributed to both of these drugs are cleared out of your system by your kidneys. taking them together can increase the levels of the drugs in your blood or put extra stress on your kidneys.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between emtricitabine/tenofovir and ganciclovir - always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.